Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy

Medicine & Life Sciences

• Tumor-Infiltrating Lymphocytes 100%
• Cell- and Tissue-Based Therapy 74%
• Practice Guidelines 73%
• Guidelines 50%
• Patient Care 13%
• Toxicity Tests 12%
• Tissue and Organ Procurement 10%
• Practice Management 10%
• Oncologists 9%
• United States Food and Drug Administration 8%
• Standard of Care 8%
• Nurses 6%
• Clinical Trials 5%
• Neoplasms 5%
• Physicians 5%
• Safety 5%
• Therapeutics 2%